Interestingly, in patients with pancreatic cancer, on the other hand, no significant association between BMI and direct mean levels of the examined substances was observed, except for the osteonectin/osteopontin ratio, which was strongly associated with BMI (r = 0.52, P < 0.05). The gene discussed is SPARC; the disease is familial pancreatic carcinoma.